- Home
- OBIO vs PFD Comparison
OBIO vs PFD Comparison
Compare OBIO & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PFD
- Stock Information
- Founded
- OBIO 2017
- PFD 1990
- Country
- OBIO United States
- PFD United States
- Employees
- OBIO N/A
- PFD N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PFD Investment Managers
- Sector
- OBIO Health Care
- PFD Finance
- Exchange
- OBIO Nasdaq
- PFD Nasdaq
- Market Cap
- OBIO 151.3M
- PFD 144.5M
- IPO Year
- OBIO N/A
- PFD N/A
- Fundamental
- Price
- OBIO $2.65
- PFD $11.08
- Analyst Decision
- OBIO Strong Buy
- PFD
- Analyst Count
- OBIO 5
- PFD 0
- Target Price
- OBIO $14.20
- PFD N/A
- AVG Volume (30 Days)
- OBIO 959.6K
- PFD 33.2K
- Earning Date
- OBIO 05-16-2025
- PFD 01-01-0001
- Dividend Yield
- OBIO N/A
- PFD 6.30%
- EPS Growth
- OBIO N/A
- PFD N/A
- EPS
- OBIO N/A
- PFD N/A
- Revenue
- OBIO $2,638,000.00
- PFD N/A
- Revenue This Year
- OBIO $13.87
- PFD N/A
- Revenue Next Year
- OBIO $32.19
- PFD N/A
- P/E Ratio
- OBIO N/A
- PFD N/A
- Revenue Growth
- OBIO N/A
- PFD N/A
- 52 Week Low
- OBIO $2.43
- PFD $8.53
- 52 Week High
- OBIO $8.87
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- OBIO 43.61
- PFD 58.60
- Support Level
- OBIO $2.37
- PFD $10.95
- Resistance Level
- OBIO $2.99
- PFD $11.10
- Average True Range (ATR)
- OBIO 0.33
- PFD 0.10
- MACD
- OBIO 0.05
- PFD 0.04
- Stochastic Oscillator
- OBIO 32.18
- PFD 88.54
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.